The COVID-19 pandemic accelerated a seismic shift in pharmaceutical market research, with telehealth and remote data collection emerging as permanent fixtures. Lockdowns forced pharma firms to abandon in-person patient interviews and clinic-based data collection, driving adoption of virtual tools like video consultations, mobile apps, and remote monitoring devices. Today, even as restrictions...